SANGUINE 6 LTD

Company Registration Number:
11806020 (England and Wales)

Unaudited micro entity accounts for the year ended 29 February 2024

Period of accounts

Start date: 01 March 2023

End date: 29 February 2024

SANGUINE 6 LTD

Contents of the Financial Statements

for the Period Ended 29 February 2024

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

SANGUINE 6 LTD

Company Information

for the Period Ended 29 February 2024




Director: GERARD EDO LLARDEN
Secretary: SHILIN SONG
Registered office: 20-22
Wenlock Road
London
England
N1 7GU
Company Registration Number: 11806020 (England and Wales)

SANGUINE 6 LTD

Balance sheet

As at 29 February 2024


2024
£

2023
£
Current assets: 55,266 21,732
Creditors: amounts falling due within one year: ( 44,762 ) ( 15,638 )
Net current assets (liabilities): 10,504 6,094
Total assets less current liabilities: 10,504 6,094
Total net assets (liabilities): 10,504 6,094
Capital and reserves: 10,504 6,094

SANGUINE 6 LTD

Balance sheet continued

For the year ending 29 February 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 7 November 2024
And Signed On Behalf Of The Board By:

Name: GERARD EDO LLARDEN
Status: Director

The notes form part of these financial statements

SANGUINE 6 LTD

Footnotes to the Financial Statements

for the Period Ended 29 February 2024

  • 1. Employee Information

    Average number of employees: 0

SANGUINE 6 LTD

Footnotes to the Financial Statements

for the Period Ended 29 February 2024

  • 2. Off balance sheet disclosure

    No